TickerGraveyard

CUTR

Bankrupt
CUTERA INC

CUTR — Post-Mortem

Cutera, Inc., a provider of aesthetic laser and light-based technologies, experienced a peak in its market presence in the mid-2010s, driven by demand for non-invasive cosmetic treatments. However, its corporate trajectory changed dramatically, culminating in a bankruptcy filing in March 2025 amid mounting financial challenges, including failure to comply with Nasdaq listing requirements. On March 6, 2025, Nasdaq notified Cutera of its intent to delist the company, which the firm formalized on March 10 by submitting a notice of voluntary delisting. As per plans stated in its filing, Cutera aimed to delist from the Nasdaq Global Select Stock Market and transition to potential trading on alternative markets, underscoring a significant shift in its operational viability and public market role

Cutera, Inc. was delisted from Nasdaq on March 30, 2025, following its Chapter 11 bankruptcy filing on March 5, 2025, marking the company's decline in financial viability and public market presence.

Could I Have Seen This Coming?

No structured pre-delisting signals found in our records. Absence of signals does not imply absence of risk.

Post-Mortem Analysis

Five-section narrative grounded in primary filings and contemporaneous reporting.

Origin

Cutera, Inc. was formed in 1998, positioning itself in the laser aesthetics sector and achieved initial growth through technological innovation in skin treatment.

Peak

The company reached its market zenith in the mid-2010s, marked by a rapidly expanding portfolio and contributed significant revenue from a growing customer base seeking non-invasive cosmetic solutions.

Turning Point

Significant declines in revenue and increased competition in the aesthetics market began to negatively impact earnings starting in late 2020, foreshadowing the financial issues that would follow.

End

On March 5, 2025, Cutera filed for Chapter 11 bankruptcy, subsequently leading Nasdaq to notify the company of its delisting on March 6, further formalized by their notice on March 10, 2025. The company voluntarily sought to end its public trading status, acknowledging insurmountable financial difficulties.

Impact

The delisting marked the exit of a once-prominent player in the aesthetic medical equipment market from the public eye, reflecting broader challenges within the sector and raising concerns regarding the sustainability of niche market players.

Lessons for Today's Investors

Transferable patterns identified from this case, written as research-report observations.

  1. 1

    Investing in niche markets requires a thorough analysis of competitive dynamics, as failure to innovate or adapt can lead to dramatic declines.

  2. 2

    Monitoring financial compliance with stock exchange requirements is crucial for shareholders, as failure to do so can result in unexpected delistings.

  3. 3

    Investors should assess the viability of a company’s business model in changing market conditions, particularly in sectors affected by rapid technology evolution.

Frequently Asked Questions

When did Cutera, Inc. file for bankruptcy?
Cutera, Inc. filed for Chapter 11 bankruptcy on March 5, 2025, due to financial challenges.
When was Cutera, Inc. officially delisted from Nasdaq?
The delisting was effective on or about March 30, 2025, following a notification from Nasdaq on March 6, 2025.
Is Cutera, Inc. listed on another exchange?
The company has not secured an alternative listing and may only be quoted on the OTC market if conditions are met.

Source Filings

Every fact on this page is anchored to a primary SEC filing or regulatory record. Open any source to verify against the original document.

Narrative sections on this page are AI-assisted summaries of the filings linked above. All content is reviewed against primary sources; if you find an error, the canonical record is always the linked filing.